Skip to content
10-Q/A

Quarterly Report

SAFECODE DRUG TECHNOLOGIES CORP.

0001144204-12-068331

← back to feed
Filed
Dec 18, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Sep 30, 2012 50M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$29.71K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$60.85K
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$10.35K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $103.7K
Cash And Equivalents Q3 2012 · Dec 31, 2011 $0
Cash And Equivalents Q3 2012 · Sep 30, 2011 $0
Cash And Equivalents Q3 2012 · Dec 31, 2010 $0
Cash And Equivalents Q3 2012 · Nov 30, 2010 $0
Cash And Equivalents Q3 2012 · Nov 22, 2010 $0
Stockholders Equity Q3 2012 · Sep 30, 2012 −$7.91K
Stockholders Equity Q3 2012 · Dec 31, 2011 −$50.62K
Stockholders Equity Q3 2012 · Dec 31, 2010 −$11.76K
Stockholders Equity Q3 2012 · Nov 22, 2010 $0
Current Liabilities Q3 2012 · Sep 30, 2012 $111.61K
Current Liabilities Q3 2012 · Dec 31, 2011 $70.62K
Total Liabilities Q3 2012 · Sep 30, 2012 $111.61K
Total Liabilities Q3 2012 · Dec 31, 2011 $70.62K
Current Assets Q3 2012 · Sep 30, 2012 $103.7K
Current Assets Q3 2012 · Dec 31, 2011 $20K
Total Assets Q3 2012 · Sep 30, 2012 $103.7K
Total Assets Q3 2012 · Dec 31, 2011 $20K
Net Income Q3 2012 · Sep 30, 2012 −$21.01K
Net Income Q3 2012 · Sep 30, 2012 −$37.29K
Net Income Q3 2012 · Sep 30, 2012 −$90.91K
Net Income Q3 2012 · Dec 31, 2011 −$41.86K
Net Income Q3 2012 · Sep 30, 2011 −$5.3K
Net Income Q3 2012 · Sep 30, 2011 −$15.95K
Net Income Q3 2012 · Dec 31, 2010 −$11.76K
Operating Income Q3 2012 · Sep 30, 2012 −$21.01K
Operating Income Q3 2012 · Sep 30, 2012 −$43.11K
Operating Income Q3 2012 · Sep 30, 2012 −$96.73K
Operating Income Q3 2012 · Sep 30, 2011 −$5.3K
Operating Income Q3 2012 · Sep 30, 2011 −$15.95K
Revenue Q3 2012 · Sep 30, 2012 $0
Revenue Q3 2012 · Sep 30, 2012 $0
Revenue Q3 2012 · Sep 30, 2012 $0
Revenue Q3 2012 · Sep 30, 2011 $0
Revenue Q3 2012 · Sep 30, 2011 $0